[Cell therapy for Parkinson's disease: IV. Risks and future trends]
Advances in Gerontology = Uspekhi Gerontologii
|March 10, 2010
Summary
Cell therapy shows promise for Parkinson's disease by replacing lost neurons. However, ethical, safety, and technical challenges hinder the widespread clinical application of stem cell treatments.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Cell Biology
Background:
- Parkinson's disease (PD) is characterized by the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to motor dysfunction.
- Cell replacement therapy is a key strategy for PD treatment, utilizing various cell sources.
Purpose of the Study:
- To provide a comprehensive overview of cell therapy approaches for Parkinson's disease.
- To discuss the potential and challenges of different cell types, including stem cells, for PD treatment.
Main Methods:
- Review of existing literature on cell therapy for Parkinson's disease.
- Analysis of different cell sources: embryonic/adult donor tissue, human mesenchymal stem cells (hMSCs), human neural stem cells (hNSCs), and human embryonic stem cells (hESCs).
Main Results:
- Various cell types, including stem cells, have been explored for Parkinson's disease therapy.
- Significant progress has been made, but ethical, safety, and technical issues remain barriers to clinical application.
Conclusions:
- Stem cell-based therapies offer potential for Parkinson's disease treatment but require further research to overcome existing challenges.
- A balanced understanding of cell subtypes, handling protocols, transplantation, and safety is crucial for advancing cell therapy in PD.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.